Does Immunohistochemistry Affect Response to Therapy and Survival of Inoperable Non–Small Cell Lung Carcinoma Patients? A Survey of 145 Stage III-IV Consecutive Cases

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Surgical Pathology

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1066896913511527PMID 24326823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WHO classification of tumours of the lung, pleura, thymus and heart

  2015cited by this paper
• Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma.

  2014cited by this paper
• A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma

  2013cited by this paper
• Simultaneous Multi-Antibody Staining in Non-Small Cell Lung Cancer Strengthens Diagnostic Accuracy Especially in Small Tissue Samples

  2013cited by this paper
• Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.

  2013cited by this paper
• Subtyping Non–Small Cell Lung Cancer

  2013cited by this paper
• New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.

  2013cited by this paper
• Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.

  2013cited by this paper
• Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.

  2013cited by this paper
• Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer.

  2013cited by this paper
• Disease-targeted sequencing: a cornerstone in the clinic

  2013cited by this paper
• Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.

  2013cited by this paper
• Toward Personalized Medicine of Lung Cancer

  2013cited by this paper
• ΔNp63 (p40) Distribution Inside Lung Cancer

  2013influential reference
• Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma

  2012cited by this paper
• Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.

  2012cited by this paper
• &Dgr;Np63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach

  2012cited by this paper
• Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact.

  2012cited by this paper
• Predicting pulmonary adenocarcinoma outcome based on a cytology grading system

  2012cited by this paper
• Revolution in lung cancer: new challenges for the surgical pathologist.

  2012cited by this paper
• Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large cell carcinoma

  2012cited by this paper
• p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma

  2012cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2012cited by this paper
• Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations

  2012cited by this paper
• Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene.

  2012cited by this paper
• A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma

  2012cited by this paper
• Large‐scale comparative analyses of immunomarkers for diagnostic subtyping of non‐small‐cell lung cancer biopsies

  2012cited by this paper
• Subtyping of Non-small Cell Lung Carcinoma: A Comparison of Small Biopsy and Cytology Specimens

  2011cited by this paper
• Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

  2011cited by this paper
• Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.

  2011cited by this paper
• Adenosquamous lung carcinomas: a histologic subtype with poor prognosis.

  2011cited by this paper
• Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing

  2011cited by this paper
• Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.

  2011cited by this paper
• Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine‐needle aspiration cytology

  2011cited by this paper
• Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens

  2011cited by this paper
• Revolution in lung cancer: new challenges for the surgical pathologist.

  2011cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2011cited by this paper
• Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing.

  2011cited by this paper
• Genomic pathology: challenges for implementation.

  2011cited by this paper
• The new taxonomy of lung adenocarcinoma stemming from a multidisciplinary integrated approach: novel pathology concepts and perspectives.

  2011cited by this paper
• New driver mutations in non-small-cell lung cancer.

  2011cited by this paper
• A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer

  2011cited by this paper
• Impact of histopathological diagnosis with ancillary immunohistochemical studies on lung cancer subtypes incidence and survival: a population-based study.

  2011cited by this paper
• A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

  2010cited by this paper
• Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy.

  2010cited by this paper
• Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift.

  2010cited by this paper
• The Classification of Lung Carcinoma: Time to Change the Morphology-Based Approach?

  2010cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Large Cell Carcinoma of the Lung: An Endangered Species?

  2009cited by this paper
• Clinicopathologic Features and Prognostic Significance of Lung Tumours with Mixed Histologic Patterns

  2009cited by this paper
• Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer.

  2009cited by this paper
• Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung.

  2008cited by this paper
• Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases.

  2007cited by this paper
• Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.

  2006cited by this paper
• Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation

  2006cited by this paper
• TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.

  2004cited by this paper
• Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung

  2001cited by this paper
• Histological Typing of Lung and Pleural Tumours

  1999cited by this paper
• Histological Classification of Lung and Pleural Tumours

  1999cited by this paper

• Mutation profile and programmed death ligand 1 status of patients with non‐small cell lung cancer diagnosed with “adenocarcinoma” and “non‐small cell carcinoma favor adenocarcinoma”

  2024cites this paper
• Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer

  2020cites this paper
• Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified

  2019cites this paper
• Non–Small‐cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non–Small‐cell Lung Cancer Favor Adenocarcinoma

  2017cites this paper
• arcinome à grandes cellules , carcinome ymphoepithelioma-like , carcinome NUT arge cell carcinoma , lymphoepithelioma-like carcinoma , NUT carcinoma

  2016cites this paper
• [Large cell carcinoma, lymphoepithelioma-like carcinoma, NUT carcinoma].

  2016cites this paper
• The impact of immunohistochemistry on the classification of lung tumors

  2016influential citation
• Large cell carcinoma of the lung: a tumor in search of an author. A clinically oriented critical reappraisal.

  2015cites this paper
• Impact of Non–Small-Cell Lung Cancer-Not Otherwise Specified Immunophenotyping on Treatment Outcome

  2014cites this paper